Nina Agabian

Title: Nina Agabian: Innovator in Immunology

Introduction

Nina Agabian is a prominent inventor based in San Francisco, CA (US). She has made significant contributions to the field of immunology, particularly in the development of methods for detecting chlamydial antigens and antibodies. With a total of 3 patents to her name, her work has had a lasting impact on medical diagnostics.

Latest Patents

Nina Agabian's latest patents include innovative methods and compositions for the production of polypeptides that are immunologically cross-reactive with the major outer membrane protein (MOMP) of Chlamydia trachomatis. One of her notable patents describes a DNA construct that includes a replication system recognized by E. coli, along with an MOMP gene under the transcriptional control of a β-galactosidase promoter and terminator. Additionally, recombinant phage λgt11/L2/33 was deposited at the American Type Culture Collection on January 10, 1985, and granted accession number 40157. Another DNA construct, L2 B9-F, was deposited on December 31, 1985, and granted accession number 40217.

Career Highlights

Throughout her career, Nina has worked with esteemed organizations such as the Washington Research Foundation and Chiron Corporation. Her expertise in immunology has allowed her to develop groundbreaking technologies that enhance the understanding and detection of infectious diseases.

Collaborations

Nina Agabian has collaborated with notable professionals in her field, including Richard Stephens and Cho-chou Kuo. These partnerships have contributed to her innovative research and development efforts.

Conclusion

Nina Agabian's contributions to immunology and her innovative patents have established her as a key figure in the field. Her work continues to influence medical diagnostics and research, showcasing the importance of innovation in healthcare.